It has also been approved to reduce the risk of heart attack, stroke, or death in adults with type 2 diabetes and known heart disease Rybelsus (Tablet): Rybelsus, the first and only oral GLP-1 analog, was approved in 2019 to improve blood sugar regulation in adults with type 2 diabetes Wegovy (Injectable): Wegovy, approved in 2021, is specifically indicated as a weight loss drug in adults with obesity or excess weight, who also have weight-related medical problems These FDA-approved medications have undergone rigorous testing to assess their safety and effectiveness for their respective indications
GLP-1 receptor agonists (like semaglutide and tirzepatide) influence multiple metabolic systems, so proper monitoring requires a panel of biomarkers, not a single measurement
Specifically, nodules were detected in fewer than 1% of patients in semaglutide arms, matching the background rate of nodule discovery in the general population during standard ultrasound screening
Changes in weather or spending more time in air-conditioned spaces can also make you feel cold
AggarwalPDuttaGShauryaRRajendranVThirunavukkarasuPCharanJet al
